Vet360 Issue 6 Volume 2 | Page 9

ENDOCRINOLOGY Dealing With Incidental Adrenal Tumours Dr Frank Kettner BVSc MMedVet(Med), DipECVIM(CA), Tygerberg Animal Hospital – Bellville, Cape Town [email protected], Tel (021) 919 1191 An adrenal “incidentaloma” is an adrenal mass, found as an incidental finding during ultrasound or CT examination of the abdomen, where adrenal pathology is not initially suspected In humans the incidence varies from <1% to 7%, and increases with the age of the population In canine and feline veterinary patients, most incidentally discovered adrenal masses, in otherwise healthy patients, are non-functional benign tumours or nonneoplastic lesions. Most functional adrenal masses are either cortisol secreting tumours or pheochromocytomas. In veterinary medicine there is no consensus on the best approach to an incidentaloma. Deciding upon an appropriate treatment plan requires classification of the incidentaloma as malignant or benign and functional or non-functional. Normal adrenal gland anatomy and physiology The adrenal gland consists of an outer cortex and an inner medulla. The latter is the site of catecholamine production. The cortex has 3 zones: from the outside to the inside these are the zona glomerulosa, the zona fasciculata and the zona reticularis. The zona glomerulosa is responsible for the production of mineralocorticoids (aldosterone). Glucocorticoids (cortisol) and androgens are synthesized in both the zona fasciculata and reticularis. In human medicine the causes for adrenal masses include: a. Functional masses (up to 15%): adenoma (aldosterone or cortisol); carcinoma (any adrenal hormone); pheochromocytoma; congenital adrenal hyperplasia; massive macro nodular adrenal disease; nodular variant of Cushing’s disease b. Non-functional masses: adenoma; myelolipoma; neuroblastoma; ganglioneuroma; haemangioma; carcinoma; metastasis; cyst; haemorrhage; granuloma; amyloidosis; infiltrative disease Hormones that are released from functional masses include: cortisol or one of the precursors (Cushing’s disease); aldosterone (Conn’s syndrome); sex hormones and adrenalin (pheochromocytoma). The canine patient may be completely asymptomatic, as would be expected in a non-functional, small benign adrenal adenoma. Patients with functional adrenal masses may present with signs of the underlying hormone excess. Animals with malignant tumours (functional or non-functional), may show non-specific signs such as decreased appetite, weight loss, lethargy and nausea. Should metastasis be present, clinical signs will further depend on the organ/s which have been affected. Surgical removed of functional or malignant adrenal masses would be ideal. However, not every mass needs to be removed and surgery holds significant risks to the patient, either due to age related anaesthetic issues, co-existing morbidity or due to surgical complications. On the other hand, surgically removing a pre-metastatic adrenal malignancy may be lifesaving. General guidelines for surgical removal include masses that are larger than 3cm, show signs of malignancy, are functional or show invasion of the surrounding blood vessels. It may not